Facebook
Twitter
LinkedIn
ForwardGuidelines & Core Urology - SELECT FOUR BELOW
Welcome to the ABU CUC Review Article Program with CME Credit
This activity will provide 1.0 AMA PRA Category 1 CreditTM per article with a passing rate of 80%. The total number of CME credit available for Activity #1 is 8 hours. CME will only be available through October 31.
You will only have one chance to take each assessment. The results of each assessment, pass or fail, will be shared with the ABU as part of the CUC Program.
Each article will have a $15 fee for AUA members and $25 fee for non-members for a total cost of $120 member/$200 non-member.
Specific instructions on how to navigate this online activity are located under the Program tab above.
REQUIREMENTS
- Each Diplomate will be required to complete eight articles.
- Each article will have five assessment questions and the passing rate is 80%.
- Within the activity, the Diplomate will have access to all 54 articles, but will be required to only choose eight of them to complete an assessment.
- Diplomates will have until October 31 to complete the activity.
There are 54 articles available. The chart below shows the breakdown of articles.
Sections | Total # of Articles | Diplomate |
|---|---|---|
| Guidelines | 22 | Choose 4 from this group |
| Core Urology | ||
| Oncology, Urinary Diversion, and Adrenal | 32 | Choose 4 from this group |
| Calculus, Lap-Robotics, Upper tract obstruction | ||
| Sexual Dysfunction, Infertility, Infection, Andrology | ||
| General Office-based Urology |
Target Audience
- Urologist
Learning Objectives
After completing this activity, learners will be able to:
- Demonstrate an increased knowledge base of urology.
- Apply increased knowledge to improve the quality of patient care.
INSTRUCTIONS
There are TWO sections within this activity:
- Guidelines & Core Urology
- Content Specific Modules
The Diplomate will select FOUR articles under each section. To select an article:
- Navigate to the Register tab located above.
- Click on the title of the article to review.
- From the article homepage, click on the Register tab.
- Click the Add to Cart button.
- From the shopping cart, you may checkout immediately OR continue shopping to add additional articles.
Once the article has been purchased, it will automatically appear under the My Activities tab. To access the article:
- Navigate to the My Activities tab of the AUAUniversity homepage.
- Under Pending Activities, you will see the name of the article purchased.
- Select the article.
- Click on the blue Take Couse button in the Course Summary box.
- Alternatively, click on the Take Course tab and click on the blue Take Course button
- From there, you will follow the course outline to read the article, complete the assessment and course evaluation, and claim CME.
COURSE NAVIGATION
At any point, you may move back through the activity:
- To return to the list of articles within the section your are currently viewing:
- Navigate to the Overview tab of the article you are currently viewing.
- In the Course Summary box, click on the link in the Part Of: box (ex: Guidelines & Core Urology - SELECT FOUR BELOW).
- click on the Register tab.
- To return to the full list of articles under both sections:
- Navigate to the Overview tab of the activity.
- In the Course Summary box, click on the link in the Part Of: box (ex: AUA Continuing Urologic Certification (CUC) Review Articles - CME).
- click on the Register tab.
- To return to the CUC Learning Group homepage:
- Click on the left-side Home button under the Features heading.
NOTES
1. The Diplomate may only attempt each assessment one time. The AUA will not re-set the assessment if the 80% passing rate is not met.
2. Diplomates will have until October 31 to complete the activity. CME will not be awarded after October 31.
EDUCATION COUNCIL DISCLOSURES
Education Council Disclosures.pdf
COI REVIEW WORK GROUP DISCLOSURES
COI Review Work Group Disclosures.pdf
LIFE LONG LEARNING WORK GROUP DISCLOSURES
Life Long Learning Work Group Disclosures.pdf
AUA Office of Education Staff has nothing to disclose.
All relevant financial relationships have been mitigated.